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Objectives: Social anxiety disorder (SAD) is a serious and prevalent psychiatric
condition, with a heritable component. However, little is known about the character-
istics that are associated with the genetic component of SAD, the so‐called
“endophenotypes”. These endophenotypes could advance our insight in the genetic
susceptibility to SAD, as they are on the pathway from genotype to phenotype. The
Leiden Family Lab study on Social Anxiety Disorder (LFLSAD) is the first multiplex,
multigenerational study aimed to identify neurocognitive endophenotypes of social
anxiety.
Methods: The LFLSAD is characterized by a multidisciplinary approach and
encompasses a variety of measurements, including a clinical interview, functional
and structural magnetic resonance imaging and an electroencephalography experi-
ment. Participants are family members from 2 generations, from families genetically
enriched for SAD.
Results: The sample (n = 132 participants, from 9 families) was characterized by a
high prevalence of SAD, in both generations (prevalence (sub)clinical SAD: 38.3%).
Furthermore, (sub)clinical SAD was positively related to self‐reported social anxiety,
fear of negative evaluation, trait anxiety, behavioral inhibition, negative affect, and
the level of depressive symptoms.
Conclusions: By the multidimensional character of the measurements and thorough
characterization of the sample, the LFLSAD offers unique opportunities to investigate
candidate neurocognitive endophenotypes of SAD.
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Social anxiety disorder (SAD) is a prevalent mental disorder, with an
estimated lifetime prevalence around 13% (Kessler, Petukhova,
Sampson, Zaslavsky, & Wittchen, 2012). Patients with SAD have an
extreme fear of being negatively evaluated by others in social
situations (American Psychiatric Association, 2013). SAD has a
considerable impact on the life of patients, as the disorder has a
typical onset during late childhood or early adolescence, and is
characterized by a chronic course (Beard, Moitra, Weisberg, & Keller,
2010; Beesdo‐Baum et al., 2012; Haller, Cohen Kadosh, Scerif, &
Lau, 2015; Miers, Blöte, de Rooij, Bokhorst, & Westenberg, 2013;
Miers, Blöte, Heyne, & Westenberg, 2014; Steinert, Hofmann,
Leichsenring, & Kruse, 2013; Westenberg, Gullone, Bokhorst, Heyne,
& King, 2007; Wittchen & Fehm, 2003). SAD patients experience
impairments in multiple domains, including education, work, and social
life; they report a lower quality of life and suffer often from comorbid
psychopathology, such as other anxiety disorders, depression, and
substance abuse (Acarturk, de Graaf, van Straten, Ten Have, &
Cuijpers, 2008; Dingemans, van Vliet, Couvée, & Westenberg, 2001;
Fehm, Pelissolo, Furmark, & Wittchen, 2005; Mack et al., 2015; Meier
et al., 2015; Stein & Stein, 2008). Insight in the factors that play a role
in the development of SAD is therefore of uttermost importance, in
order to be able to reduce long‐term effects of SAD by developing
effective preventive interventions and early treatment programs
(Beauchaine, Neuhaus, Brenner, & Gatzke‐Kopp, 2008).
Several studies have indicated that genetic predispositions, as well
as environmental, biological, and temperamental factors, interact in
the pathogenesis of SAD, as reviewed by Wong and Rapee (2016),
Spence and Rapee (2016), and Fox and Kalin (2014). Family and twin
studies pointed to a heritability of SAD of around 50% (Bandelow
et al., 2016; Gottschalk & Domschke, 2016; Isomura et al., 2015;
Smoller, 2015); however, the search for specific genes underlying
the susceptibility to SAD has been proven difficult. To start, SAD is
a heterogeneous disorder, and the diagnosis is based on clinical
assessments and not on biologically based measurements (Bearden,
Reus, & Freimer, 2004; Glahn, Thompson, & Blangero, 2007;
Gottesman & Gould, 2003). In addition, it is assumed that multiple
interacting genetic variants, with relatively small individual effects,
contribute to the vulnerability for SAD, complicating their detection
(Binder, 2012; Munafò & Flint, 2014). Furthermore, epigenetic
mechanisms, reflecting the interaction between genetic background
and environmental influences, are of importance, requiring multilevel
studies integrating data on psychopathology, (epi)genetics, and
environment (Gottschalk & Domschke, 2016; Schiele & Domschke,
2017). Given these complexities, studies into the genes that contrib-
ute to the pathophysiology may be facilitated by defining
endophenotypes related to SAD (Bas‐Hoogendam et al., 2016).
Endophenotypes are measurable characteristics on the pathway
from genotype to phenotype (Gottesman & Gould, 2003;
Lenzenweger, 2013b) and offer several possibilities to advance our
understanding of the genetic susceptibility to SAD (Bas‐Hoogendam
et al., 2016). Endophenotypes could shed light on the pathways lead-
ing to disorder phenotypes (Flint, Timpson, & Munafò, 2014; Miller &
Rockstroh, 2013), can be used to identify individuals at risk (Puls &Gallinat, 2008), and could aid in the development of animal models
for psychopathology (Gould & Gottesman, 2006). Furthermore, they
offer starting points for therapeutic interventions (Garner, Möhler,
Stein, Mueggler, & Baldwin, 2009) and can be useful in transdiagnostic
research as proposed by the NIMH Research Domain Criteria (RDoC)
(Sanislow et al., 2010). For a conceptual framework on neurobiological
endophenotypes of SAD, we refer to Bas‐Hoogendam et al. (2016).
Endophenotypes are defined as meeting the following criteria
(Glahn et al., 2007; Gottesman & Gould, 2003; Lenzenweger, 2013b;
Puls & Gallinat, 2008): (1) They are associated with the disorder; (2)
they are state‐independent traits, already present in a preclinical state;
(3) they are heritable; and (4) they cosegregate with the disorder
within families of probands, with nonaffected family members
showing altered levels of the endophenotype in comparison with the
general population. Furthermore, endophenotypes are ideally more
strongly related to the disorder of interest in comparison with other
psychiatric conditions (Lenzenweger, 2013a), but given the shared
genetic influences between psychiatric disorders, certain endophe-
notypes are likely related to more than one disorder (Cannon & Keller,
2006).1.1 | Objective of the Leiden Family Lab study on
Social Anxiety Disorder
To determine which disease‐related characteristics may serve as
endophenotypes, participants with SAD as well as their relatives need
to be extensively phenotyped. Families are essential to allow
investigating the heritability of the feature (criterion 3) and the
cosegregation of the candidate endophenotype with the disorder
within the family (criterion 4, first element), whereas case–control
studies and longitudinal studies are needed to examine the
other endophenotype criteria (criteria 1 and 2, respectively; Bas‐
Hoogendam et al., 2016). In addition, adequately matched control
families are needed to investigate the second element of criterion 4,
namely, whether nonaffected family members show altered levels of
the endophenotype when compared with the general population. To
the best of our knowledge, the Leiden Family Lab study on Social Anx-
iety Disorder (LFLSAD) is the first multiplex (i.e., multiple cases of the
disorder within one family), multigenerational family study aimed to
determine neurocognitive endophenotypes of SAD, as measured with
magnetic resonance imaging (MRI) and electroencephalography (EEG),
investigating the heritability of candidate endophenotypes and the
cosegregation of the candidate endophenotypes with the disorder
within the family. Two important aspects of the study deserve to be
highlighted.
First, the multiplex, multigenerational design was chosen to max-
imize statistical power to detect genetic and environmental influences
on SAD‐related characteristics. Having multiple cases within a family
instead of sporadic cases enriches the sample for a heritable basis of
the disease and the detection of genetic factors. Furthermore, a sam-
ple consisting of large families, composed of several related nuclear
families (parents with their children), is likely to share more heritable
factors than a same‐sized sample of unrelated nuclear families, hence
more statistical power to distinguish shared environmental effects
from genetic effects (Williams & Blangero, 1999; cf. Gur et al., 2007).
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endophenotypes as measured with MRI and EEG, as these are nonin-
vasive, widely applied, and safe methods to investigate structural and
functional properties of the human brain. Importantly, these methods
are complementary: EEG has good temporal precision to capture
electrocortical activity associated with attentional SAD‐related biases
and can be used to study candidate endophenotypes related to pro-
cessing social judgments (Harrewijn, van der Molen, van Vliet, Tissier,
& Westenberg, 2018; Van der Molen et al., 2014) and to performing a
public speaking task (Harrewijn, van der Molen, van Vliet, Houwing‐
Duistermaat, & Westenberg, 2017; Harrewijn, Van der Molen, &
Westenberg, 2016). MRI enables precise spatial localization of the
brain regions implicated in SAD and provides valuable insights in the
structure and connectivity of the brain and the functioning of brain
regions such as the amygdala and the prefrontal cortex during viewing
neutral faces in a habituation and conditioning task (cf. Bas‐
Hoogendam, van Steenbergen, Westenberg, & van der Wee, 2015;
Blackford, Allen, Cowan, & Avery, 2013; Blackford, Avery, Cowan,
Shelton, & Zald, 2011; Davis, Johnstone, Mazzulla, Oler, & Whalen,
2010) and processing social norm violations (Bas‐Hoogendam, van
Steenbergen, Kreuk, van der Wee, & Westenberg, 2017; Bas‐
Hoogendam, van Steenbergen, van der Wee, & Westenberg, 2018;
Blair et al., 2010). Typically, neurocognitive endophenotypes are
assumed to be closer to the genotype than, for example, psychological
constructs (Cannon & Keller, 2006). However, data collection in the
LFLSAD was not limited to these measures: in order to achieve com-
prehensive phenotyping of the participants, a variety of additional
measurements was included, as described in detail below. To this
aim, the LFLSAD was performed by a multidisciplinary team of clini-
cians, neuroscientists, and statisticians.
In the current paper, the design and methods of the LFLSAD are
presented. Furthermore, characteristics of the LFLSAD sample are
described, including analyses on its psychological features. Hypothe-
ses with respect to the candidate neurocognitive endophenotypes
have been preregistered in 2014 on the Open Science Framework
website (osf.io) and are available online (links provided in the
Supporting Information; Bas‐Hoogendam et al., 2014). Results of the
analyses into candidate neurocognitive endophenotypes of SAD are
reported in other papers and conference abstracts (Bas‐Hoogendam
et al., 2015; Bas‐Hoogendam, van Steenbergen, van der Wee, &
Westenberg, 2017a, 2017b; Harrewijn et al., 2018; Harrewijn, van
der Molen, et al., 2017) and in preparation.2 | METHODS
2.1 | Study design and setting
The LFLSAD is a cross‐sectional, two‐generation multiplex family
study on the neurocognitive characteristics that are genetically linked
to SAD. The study is a collaboration between Leiden University
(Institute of Psychology) and the Leiden University Medical Center
(LUMC; Departments of (Child) Psychiatry and Department of Medical
Statistics and Bioinformatics) and is embedded within the Leiden
University research profile area “Health, prevention and the humanlife cycle.” Data collection took place at Leiden University and the
LUMC between October 2013 and July 2015.2.2 | Sample
Families were considered eligible for inclusion when they contained
at least one adult, aged 25–55 years, with a primary diagnosis of
SAD (from now on referred to as the “proband”), of whom at least
one child, aged 8–21 years and living at home with the proband,
showed SAD symptoms at a clinical or subclinical level (referred to
as the “proband's SA‐child”). For these participants, comorbidity
with other internalizing disorders was allowed; however, families
were excluded when the proband or the proband's SA‐child
suffered of other psychiatric diagnoses, especially developmental
disorders (e.g., autism).
In addition to the proband and its SA‐child, the proband's spouse,
other children (age ≥8 years) and the proband's sibling(s) and their
spouse(s) with their child(ren) (age ≥8 years) were invited to partici-
pate. In Figure 1, we depict a pedigree starting with the grandparental
generation (0) on which no data were collected for reasons of feasibil-
ity; probands and siblings belonging to generation 1; and proband's
and siblings' offspring (generation 2). We aimed to include families
with at least eight family members, to enable reliable estimations of
the relation between endophenotype and SAD.
Family members of the proband and proband's SA‐child were
included independent of the presence of psychopathology. All partici-
pants were required to have sufficient comprehension of the Dutch
language.2.3 | Sample size and power calculation
The aim of the LFLSAD was twofold. First, the study aimed to
estimate the association between SAD and neurocognitive putative
endophenotypes (Bas‐Hoogendam et al., 2014; Bas‐Hoogendam
et al., 2016; Harrewijn et al., 2018; Harrewijn, Schmidt, Westenberg,
Tang, & van der Molen, 2017; Harrewijn, van der Molen, et al.,
2017); second, the significance of clustering of these endophe-
notypes within families (i.e., genetic effects) was addressed. To
estimate this heritability, a joint mixed model taking the ascertain-
ment process and familiar relationships into account will be used
(Tissier, Tsonaka, Mooijaart, Slagboom, & Houwing‐Duistermaat,
2017). Power calculations, performed by co‐author J. H. D., revealed
that 12 families with eight to 12 family members (average: 10 mem-
bers per family) were required for sufficient power (i.e., minimally
80%) to investigate these two questions (details provided in the
Supporting Information).2.4 | Procedure
2.4.1 | Recruitment
Families were recruited through media exposure, such as interviews in
Dutch newspapers, on television and radio; furthermore, the study
was brought to the attention of patient organizations such as the
“Anxiety, Compulsion and Phobia association” (in Dutch: “Angst,
Dwang en Fobie stichting”) and the “Association of Shy People”
FIGURE 1 Example of a family within the Leiden Family Lab study on Social Anxiety Disorder. Families were included based on the combination
of a parent with social anxiety disorder (SAD; “proband”: depicted in red) and a proband's child with SAD (red) or (sub)clinical SAD (orange). In
addition, family members of two generations were invited, independent from the presence of SAD within these family members (no SAD: light
blue; did not participate: gray). Grandparents (Generation 0; white) were not invited for participation. This family is slightly modified to guarantee
anonymity; however, the number of family members and the frequency of (sub)clinical SAD are depicted truthfully. Squares and circles represent
men and women, respectively
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practitioners, and mental health care organizations. In the media items,
we asked families in which multiple family members experienced
“extreme shyness” to contact us.2.4.2 | Screening procedure and inclusion of families
Potential probands were screened for eligibility by a telephone call or
an email, depending on their preference. This screening contained
questions with respect to the presence of social anxiety in the pro-
band and the proband's SA‐child, the age of the proband and his or
her child(ren), and the potential number of family members that could
be invited for the study. In addition, probands were further informed
about the study. When they passed the screening and showed interest
in participation, an information letter was sent to the proband and his
or her nuclear family members, containing detailed information about
the study. Two weeks later, participants were contacted by telephone
and any questions about the study were answered. Next, the proband,
the proband's spouse, and the proband's SA‐child were invited to
come to the LUMC for an introductory meeting and structured clinical
interview, in order to confirm the presence of a primary diagnosis of
SAD (proband) and (sub)clinical social anxiety (proband's SA‐child).
Furthermore, a screening was performed to exclude the presence of
autism in the proband and the proband's SA‐child.
When the inclusion criteria were met, the proband and his or her
nuclear family were included in the study and invited for the remaining
measurements (Table 1). In addition, we asked the proband to contact
his or her sibling(s), in order to confirm that they were interested to be
informed about participation in the study. Given a positive response,
these siblings, together with their partner and/or children, were
invited to participate by the investigators. Given the inherent charac-
teristic of socially anxious people to avoid new situations and their
tendency to stay out of the spotlights, we encouraged participants
to visit the lab together with their family members, in order to make
them feel more comfortable. Although we emphasized the importance
of including as many family members as possible within the study, we
also indicated that each individual was free to decide whether or not
to participate (Figure 1).2.4.3 | Ethics
The study (P12.061) was approved by the Medical Ethical Committee
of the LUMC in June 2012. All participants received written and verbal
information with respect to the objectives and procedure of the study;
information letters were age adjusted, to make them understandable
for children and adolescents as well. Participants provided informed
consent prior to participation, according to the Declaration of Helsinki.
Both parents signed the informed consent form for their children,
whereas children between 12 and 18 years of age signed the form
themselves as well. Every participant received €75 for participation
(duration whole test procedure, including breaks: 8 hr), and travel
expenses were reimbursed. Furthermore, participants were provided
with lunch/diner, snacks, and drinks during their visit to the lab.
Confidentiality of the research data was maintained by the use of a
unique research ID number for each participant.
2.5 | Measurements
All participants took part in the same measurements; the order of the
measurements differed between participants depending on their
availability and lab resources. However, as described above, for the
proband, the proband's spouse, and the proband's SA‐child, the clinical
interview always preceded the other measurements. Age‐appropriate
instruments were used to evaluate certain constructs. Measurements
are listed in Table 1 and explained below.
2.5.1 | Diagnosis of mental disorders
Structured clinical interviews using the Mini‐International Neuropsy-
chiatric Interview‐Plus (version 5.0.0; Sheehan et al., 1998; van Vliet
& de Beurs, 2007) or the Mini‐International Neuropsychiatric
Interview‐Kid (version 6.0; Bauhuis, Jonker, Verdellen, Reynders, &
Verbraak, 2013; Sheehan et al., 2010) were used to determine the
presence of psychiatric diagnoses according to Diagnostic and
Statistical Manual of Mental Disorders (DSM)‐IV‐R criteria (Axis 1).
Interviews were conducted by trained clinicians and were recorded.
These recordings were used to determine the presence of (sub)clinical
SAD. Clinical SAD was diagnosed using the DSM‐IV‐R criteria for the
generalized subtype of SAD, but the clinician verified whether the
TABLE 1 Measurements included in the LFLSAD
Measurement Instrument Age group (year)
Clinical Interview Diagnoses of mental (Axis 1) disorders
according to DSM criteria
MINI‐Plus 18+
MINI‐Kid 8–17
Questionnaires Social anxiety symptoms LSAS‐SR 18+
SAS‐A 8–17
Fear of negative evaluation BFNE‐II‐R 8+
General anxiety STAI trait 8+
STAI state (before and after MRI scan) 8+
Depressive symptoms BDI‐II 18+
CDI 8–17
Affect PANAS 8+
Temperament BIS/BAS 13+
BIS/BAS‐C 8–12
Autism screening AQ 18+
SRS, completed by both parents about their child(ren) 8–17
Handedness EHI 8+
Estimation of intelligence IQ WAIS‐IV subtests (similarities and block design) 17+
WISC subtests
(similarities and block design)
8–16
MRI scan Structural and functional MRI 8+
EEG experiment EEG measurement, including collection of
saliva for cortisol measurements
8+
Genotyping Collection of saliva Oragene•DNA OG‐500 kit 8+
Note. MINI‐Plus = Mini‐Plus International Neuropsychiatric Interview (MINI Plus version 5.0.0; Sheehan et al., 1998; van Vliet & de Beurs, 2007); MINI‐
Kid = MINI Kid interview version 6.0 (Bauhuis et al., 2013; Sheehan et al., 2010); LSAS‐SR = Liebowitz Social Anxiety Scale—self‐report (Fresco et al.,
2001; Mennin et al., 2002); SAS‐A = Social Anxiety Scale—adolescents (La Greca & Lopez, 1998); BFNE‐II‐R = revised Brief Fear of Negative Evaluation
II scale (Carleton et al., 2006; Leary, 1983); STAI = State–Trait Anxiety Inventory (Spielberger et al., 1970); BDI‐II = Beck Depression Inventory II (Beck et al.,
1996; Van der Does, 2002); CDI = Children's Depression Inventory (Kovacs, 1983, 1985; Timbremont & Braet, 2002); PANAS = Positive and Negative
Affect Schedule (Peeters et al., 1996; Watson et al., 1988); BIS/BAS = Behavioral Inhibition and Behavioral Activation Scales (Carver & White, 1994);
BIS/BAS‐C = Behavioral Inhibition and Behavioral Activation Scales for children (Muris et al., 2005); AQ = Autism‐Spectrum Quotient questionnaire
(Baron‐Cohen et al., 2001); SRS = Social Responsiveness Scale (Constantino et al., 2003; Roeyers et al., 2011); EHI = Edinburgh Handedness Inventory
(Oldfield, 1971); WAIS = Wechsler Adult Intelligence Scale IV (Wechsler et al., 2008); WISC = Wechsler Intelligence Scale for Children III (Wechsler,
1991); MRI = magnetic resonance imaging; EEG = electroencephalography; LFLSAD = Leiden Family Lab study on Social Anxiety Disorder.
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diagnosis. Participants were classified as having subclinical SAD when
they met the criteria for SAD as described in the DSM‐5, but
without showing obvious impairments in social, occupational, or other
important areas of functioning (Criterion G; American Psychiatric
Association, 2013).2.5.2 | Self‐report assessments of anxiety and asso-
ciated constructs
Social anxiety was assessed on a dimensional scale using the self‐
report version of the Liebowitz Social Anxiety Scale (LSAS‐SR; Fresco
et al., 2001; Mennin et al., 2002) or the Social Anxiety Scale for
Adolescents (SAS‐A; La Greca & Lopez, 1998). The LSAS‐SR measures
fear in and avoidance of situations that are likely to elicit social
anxiety, with good internal consistency (Heimberg et al., 1999). The
SAS‐A determines social anxiety in children and adolescents, with
satisfactory levels of internal consistency (Miers et al., 2013).
Fear of negative evaluation was assessed with the revised Brief
Fear of Negative Evaluation (BFNE)‐II‐R scale (Carleton, McCreary,
Norton, & Asmundson, 2006), which is a revision of the BFNE ques-
tionnaire (Leary, 1983). The BFNE‐II‐R is a self‐report questionnairewith excellent internal consistency and good convergent validity
(Carleton, Collimore, & Asmundson, 2007).
The State–Trait Anxiety Inventory (Spielberger, Gorsuch, &
Lushene, 1970; see Spielberger & Vagg, 1984, for psychometric prop-
erties) was used to determine self‐reported trait anxiety, as well as
state anxiety before and after the MRI scan.
Severity of self‐reported depressive symptoms was assessed
using the Beck Depression Inventory II (Beck, Steer, & Brown, 1996;
Van der Does, 2002) or the Children's Depression Inventory (Kovacs,
1983, 1985; Timbremont & Braet, 2002). Due to ethical reasons, an
item asking about suicide was removed from the Children's Depres-
sion Inventory (cf. Miers, Blöte, & Westenberg, 2010).
The general mood of the participant, experienced in the last
couple of weeks, was assessed by the self‐report Positive and
Negative Affect Schedule (Peeters, Ponds, & Vermeer, 1996; Watson,
Clark, & Tellegen, 1988), which is a reliable and valid instrument to
measure affect (Crawford & Henry, 2004).
The sensitivity for the temperamental traits “behavioral inhibition”
and “behavioral activation” was assessed using the self‐report BIS/
BAS (Carver & White, 1994; Franken, Muris, & Rassin, 2005) or the
BIS/BAS scales for children (BIS/BAS‐C; Muris, Meesters, de Kanter,
& Timmerman, 2005).
6 of 15 BAS‐HOOGENDAM ET AL.2.5.3 | Autism screening
Adult participants were screened for autism using the self‐report
Autism‐SpectrumQuotient questionnaire (Baron‐Cohen,Wheelwright,
Skinner,Martin, & Clubley, 2001); parents completed theDutch version
of Social Responsiveness Scale about their child(ren) (Constantino et al.,
2003; Roeyers, Thys, Druart, De Schryver, & Schittekatte, 2011).
2.5.4 | Handedness
Handedness was assessed with the Edinburgh Handedness Inventory
(Oldfield, 1971).
2.5.5 | Estimation of intelligence
Two subscales of the Wechsler Adult Intelligence Scale IV (Wechsler,
Coalson, & Raiford, 2008) or Wechsler Intelligence Scale for Children
III (Wechsler, 1991), the similarities (verbal comprehension) and block
design (perceptual reasoning) subtests, were administered to obtain an
estimate of cognitive functioning.
2.5.6 | Structural and functional MRI measurements
A detailed description of the MRI session is included in the Supporting
Information. The session consisted of a high‐resolution T1 scan, two
diffusion tensor imaging scans, and a magnetization transfer ratio scan.
In addition, a high‐resolution EPI scan and a B0 fieldmap were
acquired. Functional MRI data were collected during resting‐state
and during two functional paradigms: an amygdala paradigm investi-
gating amygdala habituation (based on the work of Blackford et al.,
2013; Blackford et al., 2011; Schwartz, Wright, Shin, Kagan, Whalen,
et al., 2003; Schwartz, Wright, Shin, Kagan, & Rauch, 2003) and
conditioning (Davis et al., 2010), and the revised Social Norm
Processing Task (Bas‐Hoogendam, van Steenbergen, Kreuk, et al.,
2017).
2.5.7 | EEG measurements
A detailed description of the EEG session is included in the Supporting
Information. The session consisted of multiple resting‐state measure-
ments, as well as two task paradigms: a social judgment paradigm
(Harrewijn et al., 2018; Van der Molen et al., 2014) and a social perfor-
mance task (Harrewijn et al., 2016; Harrewijn, van der Molen, et al.,
2017). At several time points before and during this task, task‐induced
mood was measured and saliva samples were collected to measure
cortisol.
2.5.8 | Biosampling for DNA isolation
Saliva samples were collected for future genotyping, using the
Oragene•DNA OG‐500 self‐collection kits (Genotek, Ottawa, Ontario,
Canada).2.6 | Data analysis for the current paper
2.6.1 | Sample characterization
We investigated sociodemographic differences between the genera-
tions using chi‐square tests (male/female ratio, native country, and
education level) and linear regression models (age and estimated IQ).
These regression models were fitted in R (R Core Team, 2016), withgeneration as independent variable. Because of the relationships
between the participants, genetic correlations between family mem-
bers were modeled by including random effects (lmekin function).
Next, in order to verify that the LFLSAD sample is genetically
enriched for SAD, several analyses were performed. First, the pres-
ence of clinical and subclinical SAD was determined. Furthermore,
the heritability of (sub)clinical SAD within the sample was estimated
using the software package SOLAR (Sequential Oligogenic Linkage
Analysis Routines; Almasy & Blangero, 1998). Heritability indicates
how strong genetic effects influence a certain trait and is defined as
the proportion of the variation in a phenotype that can be attributed
to additive genetic effects (Almasy & Blangero, 2010; Wray &
Visscher, 2008). SOLAR uses maximum likelihood techniques to
attribute variance in the phenotype to either genetic or environmental
effects, based on a kinship matrix for the genetic component and an
identity matrix for the unique environmental component. Here, we
did not include a shared environmental component, to keep the model
as simple as possible. We corrected for ascertainment (de Andrade &
Amos, 2000) by indicating that families were selected based on the
proband and the proband's SA‐child. Age and gender were included
as covariates and were removed from the model when their effect
was not significant (p > .05).2.6.2 | Characterization of participants with and
without (sub)clinical SAD
To further characterize the sample, we investigated differences
between participants with and without (sub)clinical SAD with respect
to male/female ratio, generation, presence of (comorbid) psychopa-
thology (chi‐square tests; Bonferroni‐corrected p value for psychopa-
thology: p = .003 [15 tests]), age, and estimated IQ (regression
models with genetic correlations as random effects). Furthermore,
we examined the relationships between (sub)clinical SAD and self‐
reported levels of anxiety and anxiety‐related constructs. When differ-
ent questionnaires were used for adults and children/adolescents, z
scores were used (see Supporting Information for reference
values). The following constructs were investigated: level of social
anxiety (z score), level of fear of negative evaluation, level of depres-
sive symptoms (z score), level of negative affect, level of trait anxiety,
and the level of inhibited temperament (z score). Regression models
were fitted in R, with (sub)clinical SAD as the independent variable;
the outcomes of the questionnaires were the dependent variables of
interest. Age and gender were included as covariates, and the genetic
correlations between family members were modeled by including
random effects. A Bonferroni‐corrected p value of .008 was used (six
tests).3 | RESULTS
3.1 | Recruitment and inclusion
Given the nature of SAD, recruitment of families meeting the inclusion
criteria was a time‐consuming process, taking place between Summer
2013 and Summer 2015. Nine families were included in the LFLSAD,
including 133 family members (Figure 2). All probands were recruited
FIGURE 2 Flowchart of inclusion of the Leiden Family Lab study on Social Anxiety Disorder (LFLSAD)
TABLE 2 Sociodemographic characteristics of the LFLSAD sample per generation
Generation 1 (n = 62) Generation 2 (n = 70) Statistical analysis
Gender (n) χ2(1) = 1.05, p = .38
Male/female 29/33 39/31
Age in years (mean ± SD) 46.2 ± 6.6 17.9 ± 6.2 β = −30.4, p < .001
Range 31.0–61.5 8.2–32.2
Native country (n) χ2(1) = 0.40, p = .84
The Netherlands 57 65
Other 5 5
Education level (n)a χ2(1) = 3.28, p = .19
Low 11 22
Intermediate 25 26
High 25 22
Estimated IQ (mean ± SD)b 104.0 ± 11.8 107.2 ± 10.6 β = 2.5, p = .13
Note. Education level was classified as follows: low = primary education (elementary school) and prevocational education; intermediate = higher secondary
education (higher general continued education, preuniversity secondary education) and postsecondary education (intermediate vocational education);
high = tertiary education (higher professional education, university); LFLSAD = Leiden Family Lab study on Social Anxiety Disorder.
aGeneration 1 (education completed): Data from 61 participants; Generation 2 (education completed or currently following): Data from 70 participants.
bGeneration 1: Data from 58 participants; Generation 2: Data from 66 participants.
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TABLE 3 Clinical diagnoses of DSM Axis 1 diagnoses within the
LFLSAD sample, per generation
Generation
1
Generation
2
SAD (number of cases; %)a 15; 25.9% 4; 6.1%
Subclinical SAD (number of cases; %)b 6; 11.5% 19; 30.2%
(Sub)clinical SAD—cumulative (number of
cases; %)b
21; 40.4% 23; 36.5%
Other psychopathologyc
Depressive episode—Current 1 1
Depressive episode—Past 16 9
8 of 15 BAS‐HOOGENDAM ET AL.by media exposure and contacts with patient associations, and none of
the probands had not been treated for SAD before entering the study.
Due to insufficient proficiency of the Dutch language, data of one
participant (partner of a proband's sibling) were excluded.
Sociodemographic characteristics of the remaining sample (n = 132)
are summarized in Table 2.
On average, each family contained 14.7 participating family
members (range: 4–35). The sample included 68 males and 64 females,
who were equally divided over the generations. As expected based on
the design, the generations differed significantly in age, but not in
estimated IQ (Table 2). Availability of data is illustrated in Figure 3.
Dysthymia—Current 1 2
Dysthymia—Past 1 1
Panic disorder—Lifetime 6 1
Agoraphobia—Current 5 2
Agoraphobia—Lifetime 1 1
Separation anxiety—Present n/a 1
Specific phobia—Present 2 3
Generalized anxiety disorder—Present 3 0
Obsessive–compulsive disorder—Present 1 0
Alcohol dependence—Present 1 1
Alcohol dependence—Lifetime 1 3
Drug dependence—Lifetime 1 0
Bulimia nervosa—Present 1 0
Note. SAD = social anxiety disorder; DSM = Diagnostic and Statistical Man-
ual of Mental Disorders; n/a = not assessed; LFLSAD = Leiden Family Lab
study on Social Anxiety Disorder.
aGeneration 1: Data from 58 participants; Generation 2: Data from 66 par-
ticipants (30 participants: MINI‐Plus; 36 participants: MINI‐Kid).
bGeneration 1: Data from 52 participants; Generation 2: Data from 63
participants.
cGeneration 1: Data from 58 participants; Generation 2: Data from 60 par-
ticipants (30 participants: MINI‐Plus; 30 participants MINI‐Kid).3.2 | Characterization of the LFLSAD sample
An overview of clinical diagnoses within the sample is presented in
Table 3, whereas scores on the dimensional self‐assessments of anxi-
ety and anxiety‐related constructs are displayed in Table 4. Diagnostic
interviews showed that social anxiety was highly prevalent within the
sample, in both generations: In addition to the nine probands, who
were selected based on a primary diagnosis of SAD, 10 of their family
members (generation 1: n = 6; generation 2: n = 4, of whom three
proband's SA‐children) met the criteria for clinical SAD. Furthermore,
25 family members (six of them proband's SA‐children) were classified
as having subclinical SAD. Total percentage of (sub)clinical SAD cases
within the sample was 38.3% (generation 1: 40.4%; generation 2:
36.5%). The validity of the diagnoses as established by the clinical
interviews was confirmed by the self‐report questionnaires: partici-
pants meeting the DSM criteria for generalized SAD (n = 19) also
met literature‐based cutoff scores for generalized social anxiety (a
score ≥60 on LSAS; Mennin et al., 2002, or a score ≥50 on SAS‐A;
Storch, Masia‐Warner, Dent, Roberti, & Fisher, 2004), with an average
score (±SD) of 68.1 ± 24.2 on the LSAS (n = 17) and a score of
55.5 ± 0.7 (n = 2) on the SAS‐A, whereas participants with subclinical
SAD reported scores of 38.2 ± 23.7 (LSAS; n = 12) and 37.5 ± 9.7
(SAS‐A; n = 13), respectively.
A heritability analysis using SOLAR indicated that (sub)clinical
SAD had a moderately high heritability, which was significant at trendFIGURE 3 Overview of available data within the Leiden Family Lab studlevel (h2 = 0.43, p = .09). Age and gender did not significantly influence
the model and were therefore removed (age: p = .78; gender: p = .62).
Comorbid diagnoses in the nine probands included depression
(past, n = 3), panic disorder (n = 2), agoraphobia (current, n = 2),
specific phobia (n = 1), and obsessive–compulsive disorder (n = 1).y on Social Anxiety Disorder (LFLSAD)
TABLE 4 Self‐report assessments of anxiety and associated constructs within the LFLSAD sample, per generation
Generation 1 (n = 62)
(mean ± SD; range)
Generation 2 (n = 70)
(mean ± SD; range)
LSAS‐SRa Total 31.4 ± 25.0 (2–95) 33.7 ± 23.3 (7–98)
Fear 16.1 ± 13.0 (0–52) 17.0 ± 13.2 (0–58)
Avoidance 15.3 ± 12.8 (0–50) 16.7 ± 11.1 (2–42)
SAS‐Ab Total 35.8 ± 9.2 (20–56)
Fear of negative evaluation 14.9 ± 5.2 (8–26)
Social avoidance and distress—New 13.9 ± 4.6 (6–26)
Social avoidance and distress—General 6.9 ± 2.3 (4–14)
BFNE‐II‐Rc Total 16.3 ± 11.6 (0–48) 15.0 ± 10.5 (0–47)
STAI traitd Total 36.0 ± 10.4 (20–64) 35.0 ± 8.1 (21–57)
BDIa Total 7.3 ± 8.1 (0–32) 7.6 ± 7.0 (1–30)
CDIb Total 6.6 ± 4.5 (0–23)
Positive affectd Total 32.3 ± 7.3 (15–47) 32.7 ± 5.7 (21–45)
Negative affectd Total 17.5 ± 6.9 (10–40) 16.9 ± 5.0 (10–31)
BIS‐BASe BIS—Total 19.8 ± 4.5 (7–28) 18.5 ± 3.9 (9–28)
BAS—Total 37.2 ± 5.0 (26–50) 39.1 ± 4.3 (31–48)
BIS‐BAS‐Cf BIS—Total 7.2 ± 4.2 (1–17)
BAS—Total 17.6 ± 5.2 (9–27)
Note. LSAS‐SR = Liebowitz Social Anxiety Scale—self‐report (Fresco et al., 2001; Mennin et al., 2002); SAS‐A = Social Anxiety Scale—adolescents (La Greca
& Lopez, 1998); BFNE‐II‐R = revised Brief Fear of Negative Evaluation II scale (Carleton et al., 2006; Leary, 1983); STAI = State–Trait Anxiety Inventory
(Spielberger et al., 1970); BDI‐II = Beck Depression Inventory II (Beck et al., 1996; Van der Does, 2002); CDI = Children's Depression Inventory (Kovacs,
1983, 1985; Timbremont & Braet, 2002); BIS/BAS = Behavioral Inhibition and Behavioral Activation Scales (Carver &White, 1994); BIS/BAS‐C = Behavioral
Inhibition and Behavioral Activation Scales for children (Muris et al., 2005); LFLSAD = Leiden Family Lab study on Social Anxiety Disorder.
aGeneration 1: Data from 62 participants; Generation 2: Data from 33 participants.
bGeneration 2: Data from 37 participants.
cGeneration 1: Data from 60 participants; Generation 2: Data from 70 participants.
dGeneration 1: Data from 62 participants; Generation 2: Data from 70 participants.
eGeneration 1: Data from 62 participants; Generation 2: Data from 52 participants.
fGeneration 2: Data from 18 participants.
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cated that depression (past and current, n = 24), agoraphobia (past
and current, n = 7), and panic disorder (n = 5) were most common diag-
noses in the LFLSAD sample. Furthermore, several participants met
criteria for alcohol dependence (current and lifetime, n = 6), dysthymia
(current and past, n = 5), specific phobia (n = 4), generalized anxiety
disorder (n = 3), separation anxiety (n = 1), drug dependence (n = 1),
and bulimia nervosa (n = 1; Table 3).3.3 | Characterization of participants with and
without (sub)clinical SAD
A characterization of the participants with and without (sub)clinical
SAD is presented in Table 5. There were no differences between fam-
ily members with and without (sub)clinical SAD with respect to the
presence of other DSM diagnoses (at Bonferroni‐corrected p
value < .003). However, all self‐reported measures of interest were
significantly related to (sub)clinical SAD (Table 6). Age was not a signif-
icant predictor in the models; gender was, however, significantly
related to the level of the level of behavioral inhibition (at
Bonferroni‐corrected p value < .008), the level of fear of negative eval-
uation, and the level of negative affect (at uncorrected p value < .05),
with higher levels in females compared with males.4 | DISCUSSION
Here, we describe the background, objective, design, and methods of
the LFLSAD and present data characterizing the sample. The study is
unique in several aspects.
To start, the LFLSAD is the first multiplex, multigenerational fam-
ily study on SAD, including 132 participants from nine families. The
composition of the sample (families were selected based on at least
two SAD cases within one nuclear family, multiplex, and multiple
nuclear families involving two generations from the same family were
included, multigenerational; see Figure 1) boosts statistical power to
observe genetic and environmental effects on SAD‐related traits (Wil-
liams & Blangero, 1999).
In addition, families were recruited from the general population
(Figure 2), and none of the participants with SAD within the sample
(n = 19) was treated for the disorder before entering the study. This
is in line with several reports on social anxiety, indicating that SAD is
frequently underdiagnosed because of the low help‐seeking behavior
of patients; furthermore, SAD is often not adequately recognized by
clinicians (Alonso et al., 2018; Dingemans et al., 2001; Fehm et al.,
2005; Ruscio et al., 2008). Thereby, the sample of the LFLSAD repre-
sents socially anxious families from the community (Dingemans et al.,
2001), including participants who are on a daily basis limited by their
TABLE 5 Characteristics of participants with and without (sub)clinical SAD
(Sub)clinical SAD (n = 44) No (sub)clinical SAD (n = 71) Statistical analysis
Demographics
Male/female 22/22 35/36 χ2(1) = 0.005, p = 1.00
Generation 1/Generation 2 21/23 31/40 χ2(1) = 0.18, p = 0.70
Age in years (mean ± SD) 30.0 ± 15.5 30.8 ± 15.8 β = 0.82, p = 0.78
Estimated IQ (mean ± SD) 104.6 ± 11.8 105.7 ± 10.8 β = 1.39, p = 0.50
Other psychopathologya
Depressive episode—Current 1 1 χ2(1) = 0.16, p = 1.00
Depressive episode—Past 12 11 χ2(1) = 3.00, p = 0.09
Dysthymia—Current 3 0 χ2(1) = 5.32, p = 0.047*
Dysthymia—Past 1 1 χ2(1) = 0.17, p = 1.00
Panic disorder—Lifetime 5 2 χ2(1) = 3.88, p = 0.10
Agoraphobia—Current 5 2 χ2(1) = 3.88, p = 0.10
Agoraphobia—Lifetime 0 2 χ2(1) = 1.18, p = 0.53
Separation anxiety—Present 0 1 χ2(1) = 0.63, p = 1.00
Specific phobia—Present 2 3 χ2(1) = 0.02, p = 1.00
Generalized anxiety disorder—Present 2 1 χ2(1) = 1.19, p = 0.55
Obsessive–compulsive disorder—Present 1 0 χ2(1) = 1.74, p = 0.37
Alcohol dependence—Present 1 1 χ2(1) = 0.16, p = 1.00
Alcohol dependence—Lifetime 1 3 χ2(1) = 0.25, p = 1.00
Drug dependence—Lifetime 1 0 χ2(1) = 1.78, p = 0.36
Bulimia nervosa—Present 1 0 χ2(1) = 1.74, p = 0.37
Self‐report measurements
Social anxiety symptoms (z score; mean ± SD) 3.0 ± 3.3 0.2 ± 1.8 See Table 6
Fear of negative evaluation (mean ± SD) 23.4 ± 12.5 12.5 ± 8.0 See Table 6
Trait anxiety (mean ± SD) 39.1 ± 9.6 32.9 ± 8.5 See Table 6
Behavioral inhibition (z score; mean ± SD) 0.4 ± 1.2 −0.4 ± 1.0 See Table 6
Depressive symptoms (z score; mean ± SD) 0.0 ± 0.8 −0.5 ± 0.7 See Table 6
Negative affect (mean ± SD) 20.6 ± 6.9 15.3 ± 4.7 See Table 6
Note. SAD = social anxiety disorder.
aGeneration 1: Data from 52 participants; Generation 2: Data from 57 participants (28 participants: MINI‐Plus; 29 participants MINI‐Kid).
*Significant at uncorrected p value of .05.
TABLE 6 Associations with (sub)clinical SAD
Constructs
Relation with (sub)clinical SAD Relation with age Relation with gender
n β (SE) p β (SE) p β (SE) p
Social anxiety (z score) 115 2.76 (0.45) 1.3 * 10−9** 0.02 (0.01) .10 0.40 (0.44) .36
Fear of negative evaluation 113 10.83 (1.85) 5.0 * 10−9** 0.08 (0.06) .18 4.10 (1.80) .02*
Trait anxiety 115 5.97 (1.67) 3.5 * 10−4** 0.02 (0.05) .69 3.09 (1.63) .06
Behavioral inhibition (z score) 115 0.82 (0.19) 1.7 * 10−5** 0.00 (0.01) .49 0.71 (0.19) 1.2 * 10−4**
Depressive symptoms (z score) 115 0.53 (0.14) 1.4 * 10−4** 0.00 (0.00) .37 0.17 (0.14) .20
Negative affect 115 5.32 (1.04) 3.1 * 10−7** 0.02 (0.03) .64 2.54 (1.02) .01*
Note. SAD = social anxiety disorder.
*Significant at uncorrected p value of .05.
**Significant at Bonferroni‐corrected p value of .008.
10 of 15 BAS‐HOOGENDAM ET AL.SAD symptoms (following Criterion G of the DSM‐5 definition, stating
that “the fear, anxiety, or avoidance causes clinically significant dis-
tress or impairment in social, occupational, or other important areas
of functioning”; American Psychiatric Association, 2013), but those
SAD cases are not a selection of cases who have received treatment
for SAD in the past.Next, following our criteria that were aimed to include families
who were enriched for genetic susceptibility to SAD, the disorder
was highly prevalent within the sample: although the lifetime preva-
lence of SAD is estimated to be around 13% in the general population
(Kessler et al., 2012), the prevalence of (sub)clinical SA in the sample
was 38.3%, with a heritability of 0.43. In addition, the scores on the
BAS‐HOOGENDAM ET AL. 11 of 15dimensional self‐assessments of social anxiety were also indicative of
elevated levels of social anxiety. It is interesting to note that, although
SAD is often comorbid with major depressive disorder (Meier et al.,
2015), the prevalence of depressive episodes within the sample was
in the range of the general population: the lifetime prevalence of past
and/or present depressive episodes within the LFLSAD was 22.9% (27
cases in 118 participants), whereas population studies indicated that
the lifetime prevalence of major depressive disorder within the com-
munity ranges between 17.1% (Jacobi et al., 2004) and 28.2%
(Vandeleur et al., 2017). These results suggest that the sample is spe-
cifically enriched for SAD and not for depression.
Furthermore, as the majority of the participants (n = 124) visited
the lab in Leiden and completed a variety of measurements including,
among others, a structured clinical interview, self‐report question-
naires, and collection of saliva for future genotyping (Table 1;
Figure 3), the LFLSAD sample is an extensively characterized sample.
This enables detailed (future) analyses on the relationship between
the social anxiety phenotype on the one hand and neurocognitive can-
didate endophenotypes of SAD on the other.
Here, we presented data on the relationship between (sub)clinical
SAD and anxiety‐related constructs, showing that (sub)clinical SAD is
positively related to increased levels of self‐reported social anxiety,
fear of negative evaluation, and depressive symptoms, to higher trait
anxiety, to the temperamental tendency to be behaviorally inhibited,
and to higher levels of negative affect (Table 6). These findings are
in line with previous reports indicating a relationship between (sub)
clinical social anxiety and these self‐reported traits (Bas‐Hoogendam,
van Steenbergen, Pannekoek, et al., 2017; Campbell et al., 2009;
Carleton et al., 2007; Clauss & Blackford, 2012; Goldin, Manber,
Hakimi, Canli, & Gross, 2009; Harrewijn et al., 2016; Rytwinski et al.,
2009; Stein, Chartier, Lizak, & Jang, 2001) and underscore the validity
of the LFLSAD sample.
Looking back at the power analyses performed before the start of
the study, which showed that including 12 families of on average 10
family members would result in sufficient statistical power, the actual
LFLSAD sample contains less families (i.e., nine), but with, on average,
more family members per family (14.7 family members). In comparison
with the original sample composition, this actual sample contains com-
parable statistical power to investigate candidate endophenotypes of
SAD. The first results on neurocognitive endophenotypes emerging
from the LFLSAD (Bas‐Hoogendam et al., 2015; Bas‐Hoogendam,
van Steenbergen, van der Wee, et al., 2017a, 2017b; Harrewijn
et al., 2018; Harrewijn, van der Molen, et al., 2017) underscore the
potential of such a study design.
Some limitations of the LFLSAD design should be mentioned. First
of all, the LFLSAD has a relatively small sample size, which is due to
the novelty and complexity of performing a family study in this popu-
lation. Furthermore, given the cross‐sectional nature of the study, the
LFLSAD data do not allow for testing the state independency of the
candidate neurocognitive endophenotypes (endophenotype criterion
2). In addition, as no control families were included, comparing the
levels of the candidate endophenotypes between nonaffected family
members and participants from the general population (second part
of endophenotype criterion 4) is not possible. Finally, we did not
acquire data with respect to potential environmental influences suchas traumatic life events and aversive social experiences, which could
play an important role in the etiology and maintenance of SAD (Brook
& Schmidt, 2008; Norton & Abbott, 2017; Wong & Rapee, 2016).5 | CONCLUSION
To conclude, the LFLSAD provides a unique opportunity to examine
candidate neurocognitive endophenotypes of this serious disorder. It
is our hope that the results of this study will provide clues for
future‐directed gene linkage studies, to gain more insight in the
genetic vulnerability for SAD.
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